Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The interspecific growth-mortality trade-off is not a general framework for tropical forest community structure.
Russo SE, McMahon SM, Detto M, Ledder G, Wright SJ, Condit RS, Davies SJ, Ashton PS, Bunyavejchewin S, Chang-Yang CH, Ediriweera S, Ewango CEN, Fletcher C, Foster RB, Gunatilleke CVS, Gunatilleke IAUN, Hart T, Hsieh CF, Hubbell SP, Itoh A, Kassim AR, Leong YT, Lin YC, Makana JR, Mohamad MB, Ong P, Sugiyama A, Sun IF, Tan S, Thompson J, Yamakura T, Yap SL, Zimmerman JK. Russo SE, et al. Among authors: sugiyama a. Nat Ecol Evol. 2021 Feb;5(2):174-183. doi: 10.1038/s41559-020-01340-9. Epub 2020 Nov 16. Nat Ecol Evol. 2021. PMID: 33199870
Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.
Fukunaga A, Kakei Y, Murakami S, Kan Y, Masuda K, Jinnin M, Washio K, Amano H, Nagano T, Yamamoto A, Otsuka T, Takahagi S, Takenaka M, Ishiguro N, Hayama K, Inomata N, Nakagawa Y, Sugiyama A, Hide M. Fukunaga A, et al. Among authors: sugiyama a. Front Immunol. 2024 Sep 16;15:1441478. doi: 10.3389/fimmu.2024.1441478. eCollection 2024. Front Immunol. 2024. PMID: 39351222 Free PMC article. Clinical Trial.
In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction.
Kambayashi R, Goto A, Shinozaki M, Izumi-Nakaseko H, Takei Y, Iwata K, Kaneko N, Sugiyama A. Kambayashi R, et al. Among authors: sugiyama a. J Pharmacol Sci. 2024 Nov;156(3):171-179. doi: 10.1016/j.jphs.2024.08.004. Epub 2024 Aug 22. J Pharmacol Sci. 2024. PMID: 39313275 Free article.
Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey.
Kobashi Y, Kawamura T, Shimazu Y, Kaneko Y, Nishikawa Y, Sugiyama A, Tani Y, Nakayama A, Yoshida M, Zho T, Yamamoto C, Saito H, Takita M, Wakui M, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: sugiyama a. Vaccine X. 2024 Sep 12;20:100553. doi: 10.1016/j.jvacx.2024.100553. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39309610 Free PMC article.
SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study.
Watanabe S, Sawano T, Saito H, Ozaki A, Wakui M, Zhao T, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Shimmura H, Tsubokura M. Watanabe S, et al. Among authors: sugiyama a. Front Immunol. 2024 Aug 21;15:1412918. doi: 10.3389/fimmu.2024.1412918. eCollection 2024. Front Immunol. 2024. PMID: 39238641 Free PMC article.
1,126 results